» Articles » PMID: 22184411

MicroRNA-27a/b Controls Endothelial Cell Repulsion and Angiogenesis by Targeting Semaphorin 6A

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2011 Dec 21
PMID 22184411
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRs) are small RNAs that regulate gene expression at the posttranscriptional level. miR-27 is expressed in endothelial cells, but the specific functions of miR-27b and its family member miR-27a are largely unknown. Here we demonstrate that overexpression of miR-27a and miR-27b significantly increased endothelial cell sprouting. Inhibition of both miR-27a and miR-27b impaired endothelial cell sprout formation and induced endothelial cell repulsion in vitro. In vivo, inhibition of miR-27a/b decreased the number of perfused vessels in Matrigel plugs and impaired embryonic vessel formation in zebrafish. Mechanistically, miR-27 regulated the expression of the angiogenesis inhibitor semaphorin 6A (SEMA6A) in vitro and in vivo and targeted the 3'-untranslated region of SEMA6A. Silencing of SEMA6A partially reversed the inhibition of endothelial cell sprouting and abrogated the repulsion of endothelial cells mediated by miR-27a/b inhibition, indicating that SEMA6A is a functionally relevant miR-27 downstream target regulating endothelial cell repulsion. In summary, we show that miR-27a/b promotes angiogenesis by targeting the angiogenesis inhibitor SEMA6A, which controls repulsion of neighboring endothelial cells.

Citing Articles

Sensory nerve EP4 facilitates heterotopic ossification by regulating angiogenesis-coupled bone formation.

Lin R, Lin H, Zhu C, Zeng J, Hou J, Xu T J Orthop Translat. 2024; 49:325-338.

PMID: 39568804 PMC: 11576939. DOI: 10.1016/j.jot.2024.09.005.


Heterogeneity and Differentiation of the Human Arterial Tree: Focus on microRNA Expression in Vascular Disease.

Ciavarella C, Motta I, Capri M, Gargiulo M, Pasquinelli G Biomolecules. 2024; 14(3).

PMID: 38540762 PMC: 10967886. DOI: 10.3390/biom14030343.


Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies.

Pathak A, Pal A, Roy S, Nandave M, Jain K Stem Cells Int. 2024; 2024:9077926.

PMID: 38213742 PMC: 10783989. DOI: 10.1155/2024/9077926.


Long-Term LDL-Apheresis Treatment and Dynamics of Circulating miRNAs in Patients with Severe Familial Hypercholesterolemia.

Dlouha D, Blaha M, Huckova P, Lanska V, Hubacek J, Blaha V Genes (Basel). 2023; 14(8).

PMID: 37628623 PMC: 10454435. DOI: 10.3390/genes14081571.


Lipid Nanoparticles as a Shuttle for Anti-Adipogenic miRNAs to Human Adipocytes.

Schachner-Nedherer A, Fuchs J, Vidakovic I, Holler O, Schratter G, Almer G Pharmaceutics. 2023; 15(7).

PMID: 37514169 PMC: 10384627. DOI: 10.3390/pharmaceutics15071983.